Search research articles
Contact Us
Filters
Showing results (131-140 of 138) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 138 results.
The Journal of Urology
|
April 20, 2010
Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients
Giacomo Novara, Robert S Svatek, Pierre I Karakiewicz, et al.
Urology
|
February 4, 2014
Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis
Jamie C Messer, Shahrokh F Shariat, Colin P Dinney, et al.
The Journal of Urology
|
October 20, 2009
Conditional survival predictions after nephrectomy for renal cell carcinoma
Pierre I Karakiewicz, Nazareno Suardi, Umberto Capitanio, et al.
European Urology
|
April 14, 2009
Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases
Umberto Capitanio, Shahrokh F Shariat, Hendrik Isbarn, et al.
European Urology
|
June 20, 2015
Corrigendum to "Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort" [Eur Urol 2010;57:300-9]
Hans-Martin Fritsche, Maximilian Burger, Robert S Svatek, et al.
European Urology
|
September 22, 2009
Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort
Hans-Martin Fritsche, Maximilian Burger, Robert S Svatek, et al.
European Urology
|
July 22, 2009
Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy
Jay D Raman, Casey K Ng, Douglas S Scherr, et al.
Therapeutic Advances in Medical Oncology
|
April 7, 2022
Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study
Klaus-Peter Dieckmann, Tomas Pokrivcak, Lajos Geczi, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 138) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 138 results.
The Journal of Urology
|
April 20, 2010
Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients
Giacomo Novara, Robert S Svatek, Pierre I Karakiewicz, et al.
Urology
|
February 4, 2014
Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis
Jamie C Messer, Shahrokh F Shariat, Colin P Dinney, et al.
The Journal of Urology
|
October 20, 2009
Conditional survival predictions after nephrectomy for renal cell carcinoma
Pierre I Karakiewicz, Nazareno Suardi, Umberto Capitanio, et al.
European Urology
|
April 14, 2009
Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases
Umberto Capitanio, Shahrokh F Shariat, Hendrik Isbarn, et al.
European Urology
|
June 20, 2015
Corrigendum to "Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort" [Eur Urol 2010;57:300-9]
Hans-Martin Fritsche, Maximilian Burger, Robert S Svatek, et al.
European Urology
|
September 22, 2009
Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort
Hans-Martin Fritsche, Maximilian Burger, Robert S Svatek, et al.
European Urology
|
July 22, 2009
Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy
Jay D Raman, Casey K Ng, Douglas S Scherr, et al.
Therapeutic Advances in Medical Oncology
|
April 7, 2022
Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study
Klaus-Peter Dieckmann, Tomas Pokrivcak, Lajos Geczi, et al.
Page
of 14